Christopher Chen, Gurleen Kaur, Puja K Mehta, Doralisa Morrone, Lucas C Godoy, Sripal Bangalore, Mandeep S Sidhu. Cardiovasc Drugs Ther 2021
Times Cited: 2
Times Cited: 2
Times Cited
Times Co-cited
Similarity
OSA and depression are common and independently associated with refractory angina in patients with coronary artery disease.
Glaucylara R Geovanini, Luis H W Gowdak, Alexandre C Pereira, Naury de Jesus Danzi-Soares, Luciana O C Dourado, Nilson T Poppi, Luiz Antonio Machado Cesar, Luciano F Drager, Geraldo Lorenzi-Filho. Chest 2014
Glaucylara R Geovanini, Luis H W Gowdak, Alexandre C Pereira, Naury de Jesus Danzi-Soares, Luciana O C Dourado, Nilson T Poppi, Luiz Antonio Machado Cesar, Luciano F Drager, Geraldo Lorenzi-Filho. Chest 2014
50
Ivabradine in chronic stable angina: Effects by and beyond heart rate reduction.
Paolo G Camici, Steffen Gloekler, Bernard I Levy, Emmanouil Skalidis, Ercole Tagliamonte, Panos Vardas, Gerd Heusch. Int J Cardiol 2016
Paolo G Camici, Steffen Gloekler, Bernard I Levy, Emmanouil Skalidis, Ercole Tagliamonte, Panos Vardas, Gerd Heusch. Int J Cardiol 2016
50
Inadequate heart rate control despite widespread use of beta-blockers in outpatients with stable CAD: findings from the international prospective CLARIFY registry.
Michal Tendera, Kim Fox, Roberto Ferrari, Ian Ford, Nicola Greenlaw, Hélène Abergel, Cezar Macarie, Jean-Claude Tardif, Panos Vardas, José Zamorano,[...]. Int J Cardiol 2014
Michal Tendera, Kim Fox, Roberto Ferrari, Ian Ford, Nicola Greenlaw, Hélène Abergel, Cezar Macarie, Jean-Claude Tardif, Panos Vardas, José Zamorano,[...]. Int J Cardiol 2014
50
Ischemia and No Obstructive Coronary Artery Disease: Prevalence and Correlates of Coronary Vasomotion Disorders.
Thomas J Ford, Eric Yii, Novalia Sidik, Richard Good, Paul Rocchiccioli, Margaret McEntegart, Stuart Watkins, Hany Eteiba, Aadil Shaukat, Mitchell Lindsay,[...]. Circ Cardiovasc Interv 2019
Thomas J Ford, Eric Yii, Novalia Sidik, Richard Good, Paul Rocchiccioli, Margaret McEntegart, Stuart Watkins, Hany Eteiba, Aadil Shaukat, Mitchell Lindsay,[...]. Circ Cardiovasc Interv 2019
50
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes.
Juhani Knuuti, William Wijns, Antti Saraste, Davide Capodanno, Emanuele Barbato, Christian Funck-Brentano, Eva Prescott, Robert F Storey, Christi Deaton, Thomas Cuisset,[...]. Eur Heart J 2020
Juhani Knuuti, William Wijns, Antti Saraste, Davide Capodanno, Emanuele Barbato, Christian Funck-Brentano, Eva Prescott, Robert F Storey, Christi Deaton, Thomas Cuisset,[...]. Eur Heart J 2020
50
Effect of Ivabradine on Endothelial Function in Patients with Stable Angina Pectoris: Assessment with the Endo-PAT 2000 Device.
Lucia Jedlickova, Lucia Merkovska, Lucia Jackova, Martin Janicko, Jan Fedacko, Bozena Novakova, Anna Chmelarova, Jaroslav Majernik, Daniel Pella. Adv Ther 2015
Lucia Jedlickova, Lucia Merkovska, Lucia Jackova, Martin Janicko, Jan Fedacko, Bozena Novakova, Anna Chmelarova, Jaroslav Majernik, Daniel Pella. Adv Ther 2015
50
The many faces of myocardial ischaemia and angina.
Bernard I Levy, Gerd Heusch, Paolo G Camici. Cardiovasc Res 2019
Bernard I Levy, Gerd Heusch, Paolo G Camici. Cardiovasc Res 2019
50
Coronary and hemodynamic effects of S 16257, a new bradycardic agent, in resting and exercising conscious dogs.
L Simon, B Ghaleh, L Puybasset, J F Giudicelli, A Berdeaux. J Pharmacol Exp Ther 1995
L Simon, B Ghaleh, L Puybasset, J F Giudicelli, A Berdeaux. J Pharmacol Exp Ther 1995
50
Characterization of the heart rate-lowering action of ivabradine, a selective I(f) current inhibitor.
Jeffrey S Borer, Jean-Yves Le Heuzey. Am J Ther 2008
Jeffrey S Borer, Jean-Yves Le Heuzey. Am J Ther 2008
50
Heart rate and use of beta-blockers in stable outpatients with coronary artery disease.
Ph Gabriel Steg, Roberto Ferrari, Ian Ford, Nicola Greenlaw, Jean-Claude Tardif, Michal Tendera, Hélène Abergel, Kim M Fox. PLoS One 2012
Ph Gabriel Steg, Roberto Ferrari, Ian Ford, Nicola Greenlaw, Jean-Claude Tardif, Michal Tendera, Hélène Abergel, Kim M Fox. PLoS One 2012
50
Changes in heart rate and heart rate variability before ambulatory ischemic events(1).
W J Kop, R J Verdino, J S Gottdiener, S T O'Leary, C N Bairey Merz, D S Krantz. J Am Coll Cardiol 2001
W J Kop, R J Verdino, J S Gottdiener, S T O'Leary, C N Bairey Merz, D S Krantz. J Am Coll Cardiol 2001
50
Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease.
Ariel Diaz, Martial G Bourassa, Marie-Claude Guertin, Jean-Claude Tardif. Eur Heart J 2005
Ariel Diaz, Martial G Bourassa, Marie-Claude Guertin, Jean-Claude Tardif. Eur Heart J 2005
50
Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study.
Emmanuelle Vidal-Petiot, Ian Ford, Nicola Greenlaw, Roberto Ferrari, Kim M Fox, Jean-Claude Tardif, Michal Tendera, Luigi Tavazzi, Deepak L Bhatt, Philippe Gabriel Steg. Lancet 2016
Emmanuelle Vidal-Petiot, Ian Ford, Nicola Greenlaw, Roberto Ferrari, Kim M Fox, Jean-Claude Tardif, Michal Tendera, Luigi Tavazzi, Deepak L Bhatt, Philippe Gabriel Steg. Lancet 2016
50
The effect of heart rate reduction by ivabradine on collateral function in patients with chronic stable coronary artery disease.
Steffen Gloekler, Tobias Traupe, Michael Stoller, Deborah Schild, Hélène Steck, Ahmed Khattab, Rolf Vogel, Christian Seiler. Heart 2014
Steffen Gloekler, Tobias Traupe, Michael Stoller, Deborah Schild, Hélène Steck, Ahmed Khattab, Rolf Vogel, Christian Seiler. Heart 2014
50
Impact of Ivabradine on Central Aortic Blood Pressure and Myocardial Perfusion in Patients With Stable Coronary Artery Disease.
Jean-Guillaume Dillinger, Vincent Maher, Cristiana Vitale, Patrick Henry, Damien Logeart, Stephane Manzo Silberman, Guillaume Allée, Bernard I Levy. Hypertension 2015
Jean-Guillaume Dillinger, Vincent Maher, Cristiana Vitale, Patrick Henry, Damien Logeart, Stephane Manzo Silberman, Guillaume Allée, Bernard I Levy. Hypertension 2015
50
Efficacy of Ivabradine in Combination with Beta-Blockers Versus Uptitration of Beta-Blockers in Patients with Stable Angina (CONTROL-2 Study).
Maria Glezer, Yuri Vasyuk, Yuri Karpov. Adv Ther 2018
Maria Glezer, Yuri Vasyuk, Yuri Karpov. Adv Ther 2018
50
Low Diastolic Blood Pressure Is Associated With Angina in Patients With Chronic Coronary Artery Disease.
Poghni A Peri-Okonny, Krishna K Patel, Philip G Jones, Tracie Breeding, Kensey L Gosch, John A Spertus, Suzanne V Arnold. J Am Coll Cardiol 2018
Poghni A Peri-Okonny, Krishna K Patel, Philip G Jones, Tracie Breeding, Kensey L Gosch, John A Spertus, Suzanne V Arnold. J Am Coll Cardiol 2018
50
Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice.
Florian Custodis, Magnus Baumhäkel, Nils Schlimmer, Franka List, Christoph Gensch, Michael Böhm, Ulrich Laufs. Circulation 2008
Florian Custodis, Magnus Baumhäkel, Nils Schlimmer, Franka List, Christoph Gensch, Michael Böhm, Ulrich Laufs. Circulation 2008
50
Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial.
Kim Fox, Ian Ford, P Gabriel Steg, Michal Tendera, Roberto Ferrari. Lancet 2008
Kim Fox, Ian Ford, P Gabriel Steg, Michal Tendera, Roberto Ferrari. Lancet 2008
50
Ivabradine and Bisoprolol on Doppler-derived Coronary Flow Velocity Reserve in Patients with Stable Coronary Artery Disease: Beyond the Heart Rate.
Ercole Tagliamonte, Teresa Cirillo, Fausto Rigo, Costantino Astarita, Antonino Coppola, Carlo Romano, Nicola Capuano. Adv Ther 2015
Ercole Tagliamonte, Teresa Cirillo, Fausto Rigo, Costantino Astarita, Antonino Coppola, Carlo Romano, Nicola Capuano. Adv Ther 2015
50
50
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.
Karl Swedberg, Michel Komajda, Michael Böhm, Jeffrey S Borer, Ian Ford, Ariane Dubost-Brama, Guy Lerebours, Luigi Tavazzi. Lancet 2010
Karl Swedberg, Michel Komajda, Michael Böhm, Jeffrey S Borer, Ian Ford, Ariane Dubost-Brama, Guy Lerebours, Luigi Tavazzi. Lancet 2010
50
Efficacy of ivabradine in combination with Beta-blocker versus uptitration of Beta-blocker in patients with stable angina.
E Amosova, E Andrejev, I Zaderey, U Rudenko, C Ceconi, R Ferrari. Cardiovasc Drugs Ther 2011
E Amosova, E Andrejev, I Zaderey, U Rudenko, C Ceconi, R Ferrari. Cardiovasc Drugs Ther 2011
50
β-adrenoceptor blockers valuable but higher doses not necessary.
Simon B Dimmitt, Hans G Stampfer, John B Warren. Br J Clin Pharmacol 2014
Simon B Dimmitt, Hans G Stampfer, John B Warren. Br J Clin Pharmacol 2014
50
Late sodium current inhibition in human isolated cardiomyocytes by R 56865.
B Le Grand, A Coulombe, G W John. J Cardiovasc Pharmacol 1998
B Le Grand, A Coulombe, G W John. J Cardiovasc Pharmacol 1998
50
Innovative approaches to anti-arrhythmic drug therapy.
Stanley Nattel, Leif Carlsson. Nat Rev Drug Discov 2006
Stanley Nattel, Leif Carlsson. Nat Rev Drug Discov 2006
50
Discovery of triazolopyridine GS-458967, a late sodium current inhibitor (Late INai) of the cardiac NaV 1.5 channel with improved efficacy and potency relative to ranolazine.
Dmitry O Koltun, Eric Q Parkhill, Elfatih Elzein, Tetsuya Kobayashi, Gregory T Notte, Rao Kalla, Robert H Jiang, Xiaofen Li, Thao D Perry, Belem Avila,[...]. Bioorg Med Chem Lett 2016
Dmitry O Koltun, Eric Q Parkhill, Elfatih Elzein, Tetsuya Kobayashi, Gregory T Notte, Rao Kalla, Robert H Jiang, Xiaofen Li, Thao D Perry, Belem Avila,[...]. Bioorg Med Chem Lett 2016
50
Optimization of Ca(v)1.2 screening with an automated planar patch clamp platform.
Bharathi Balasubramanian, John P Imredy, David Kim, Jacob Penniman, Armando Lagrutta, Joseph J Salata. J Pharmacol Toxicol Methods 2009
Bharathi Balasubramanian, John P Imredy, David Kim, Jacob Penniman, Armando Lagrutta, Joseph J Salata. J Pharmacol Toxicol Methods 2009
50
Benzopyran sulfonamides as KV1.5 potassium channel blockers.
John Lloyd, Karnail S Atwal, Heather J Finlay, Michael Nyman, Tram Huynh, Rao Bhandaru, Alexander Kover, Joan Schmidt, Wayne Vaccaro, Mary Lee Conder,[...]. Bioorg Med Chem Lett 2007
John Lloyd, Karnail S Atwal, Heather J Finlay, Michael Nyman, Tram Huynh, Rao Bhandaru, Alexander Kover, Joan Schmidt, Wayne Vaccaro, Mary Lee Conder,[...]. Bioorg Med Chem Lett 2007
50
Synthesis and pharmacological studies of N-[4-[2-hydroxy-3-[[2-[4-(1H-imidazol-1- yl)phenoxy]ethyl]amino]propoxy]phenyl]methanesulfonamide, a novel antiarrhythmic agent with class II and class III activities.
T K Morgan, R Lis, W C Lumma, R A Wohl, K Nickisch, G B Phillips, J M Lind, J W Lampe, S V Di Meo, H J Reiser. J Med Chem 1990
T K Morgan, R Lis, W C Lumma, R A Wohl, K Nickisch, G B Phillips, J M Lind, J W Lampe, S V Di Meo, H J Reiser. J Med Chem 1990
50
Herbal Medicine for Cardiovascular Diseases: Efficacy, Mechanisms, and Safety.
Abdullah Shaito, Duong Thi Bich Thuan, Hoa Thi Phu, Thi Hieu Dung Nguyen, Hiba Hasan, Sarah Halabi, Samar Abdelhady, Gheyath K Nasrallah, Ali H Eid, Gianfranco Pintus. Front Pharmacol 2020
Abdullah Shaito, Duong Thi Bich Thuan, Hoa Thi Phu, Thi Hieu Dung Nguyen, Hiba Hasan, Sarah Halabi, Samar Abdelhady, Gheyath K Nasrallah, Ali H Eid, Gianfranco Pintus. Front Pharmacol 2020
50
Electrophysiologic effects of SB-237376: a new antiarrhythmic compound with dual potassium and calcium channel blocking action.
Xiaoping Xu, Gan-Xin Yan, Ying Wu, Tengxian Liu, Peter R Kowey. J Cardiovasc Pharmacol 2003
Xiaoping Xu, Gan-Xin Yan, Ying Wu, Tengxian Liu, Peter R Kowey. J Cardiovasc Pharmacol 2003
50
Use-dependent block of the pacemaker current I(f) in rabbit sinoatrial node cells by zatebradine (UL-FS 49). On the mode of action of sinus node inhibitors.
M Goethals, A Raes, P P van Bogaert. Circulation 1993
M Goethals, A Raes, P P van Bogaert. Circulation 1993
50
Detailed insight on β-adrenoceptors as therapeutic targets.
Bharath Kumar Velmurugan, Rathinasamy Baskaran, Chih-Yang Huang. Biomed Pharmacother 2019
Bharath Kumar Velmurugan, Rathinasamy Baskaran, Chih-Yang Huang. Biomed Pharmacother 2019
50
Late Sodium Current Inhibitors as Potential Antiarrhythmic Agents.
Balázs Horváth, Tamás Hézső, Dénes Kiss, Kornél Kistamás, János Magyar, Péter P Nánási, Tamás Bányász. Front Pharmacol 2020
Balázs Horváth, Tamás Hézső, Dénes Kiss, Kornél Kistamás, János Magyar, Péter P Nánási, Tamás Bányász. Front Pharmacol 2020
50
Assessment of reverse use-dependent blocking actions of class III antiarrhythmic drugs by 24-hour Holter electrocardiography.
Y Okada, S Ogawa, T Sadanaga, H Mitamura. J Am Coll Cardiol 1996
Y Okada, S Ogawa, T Sadanaga, H Mitamura. J Am Coll Cardiol 1996
50
Arctigenin, a potential anti-arrhythmic agent, inhibits aconitine-induced arrhythmia by regulating multi-ion channels.
Zhenying Zhao, Yongqiang Yin, Hong Wu, Min Jiang, Jianshi Lou, Gang Bai, Guo'an Luo. Cell Physiol Biochem 2013
Zhenying Zhao, Yongqiang Yin, Hong Wu, Min Jiang, Jianshi Lou, Gang Bai, Guo'an Luo. Cell Physiol Biochem 2013
50
Electrophysiological effects of S 16257, a novel sino-atrial node modulator, on rabbit and guinea-pig cardiac preparations: comparison with UL-FS 49.
C Thollon, C Cambarrat, J Vian, J F Prost, J L Peglion, J P Vilaine. Br J Pharmacol 1994
C Thollon, C Cambarrat, J Vian, J F Prost, J L Peglion, J P Vilaine. Br J Pharmacol 1994
50
Emerging class III antiarrhythmic agents: mechanism of action and proarrhythmic potential.
L A Nair, A O Grant. Cardiovasc Drugs Ther 1997
L A Nair, A O Grant. Cardiovasc Drugs Ther 1997
50
Synthesis and Ca2+ antagonistic activity of 2-[2-[(aminoalkyl)oxy]-5-methoxyphenyl]-3,4-dihydro-4-methyl-3-oxo-2H- 1,4-benzothiazines.
M Fujita, S Ito, A Ota, N Kato, K Yamamoto, Y Kawashima, H Yamauchi, J Iwao. J Med Chem 1990
M Fujita, S Ito, A Ota, N Kato, K Yamamoto, Y Kawashima, H Yamauchi, J Iwao. J Med Chem 1990
50
Specific bradycardic agents. 1. Chemistry, pharmacology, and structure-activity relationships of substituted benzazepinones, a-new class of compounds exerting antiischemic properties.
M Reiffen, W Eberlein, P Müller, M Psiorz, K Noll, J Heider, C Lillie, W Kobinger, P Luger. J Med Chem 1990
M Reiffen, W Eberlein, P Müller, M Psiorz, K Noll, J Heider, C Lillie, W Kobinger, P Luger. J Med Chem 1990
50
Cardioselective beta-adrenergic blocking agents. 1. 1-((3,4-Dimethoxyphenethyl)amino)-3-aryloxy-2-propanols.
M L Hoefle, S G Hastings, R F Meyer, R M Corey, A Holmes, C D Stratton. J Med Chem 1975
M L Hoefle, S G Hastings, R F Meyer, R M Corey, A Holmes, C D Stratton. J Med Chem 1975
50
The utility of hERG and repolarization assays in evaluating delayed cardiac repolarization: influence of multi-channel block.
Ruth L Martin, Jeff S McDermott, Heinz J Salmen, Jason Palmatier, Bryan F Cox, Gary A Gintant. J Cardiovasc Pharmacol 2004
Ruth L Martin, Jeff S McDermott, Heinz J Salmen, Jason Palmatier, Bryan F Cox, Gary A Gintant. J Cardiovasc Pharmacol 2004
50
Gallopamil: cardiovascular scope of action of a highly specific calcium antagonist.
G Fleckenstein-Grün. J Cardiovasc Pharmacol 1992
G Fleckenstein-Grün. J Cardiovasc Pharmacol 1992
50
Proarrhythmic Effects Of Antiarrhythmic Drugs: Case Study Of Flecainide Induced Ventricular Arrhythmias During Treatment Of Atrial Fibrillation.
M Barman. J Atr Fibrillation 2015
M Barman. J Atr Fibrillation 2015
50
Strategies to reduce HERG K+ channel blockade. Exploring heteroaromaticity and rigidity in novel pyridine analogues of dofetilide.
João F S Carvalho, Julien Louvel, Maarten L J Doornbos, Elisabeth Klaasse, Zhiyi Yu, Johannes Brussee, Adriaan P IJzerman. J Med Chem 2013
João F S Carvalho, Julien Louvel, Maarten L J Doornbos, Elisabeth Klaasse, Zhiyi Yu, Johannes Brussee, Adriaan P IJzerman. J Med Chem 2013
50
Evidence for a sustained effectiveness of sodium-channel activators in failing human myocardium.
R H Schwinger, M Böhm, C Mittmann, K La Rosée, E Erdmann. J Mol Cell Cardiol 1991
R H Schwinger, M Böhm, C Mittmann, K La Rosée, E Erdmann. J Mol Cell Cardiol 1991
50
Editorial: Perspectives of Antiarrhythmic Drug Therapy: Disappointing Past, Current Efforts, and Faint Hopes.
Péter P Nánási, Esther Pueyo, László Virág. Front Pharmacol 2020
Péter P Nánási, Esther Pueyo, László Virág. Front Pharmacol 2020
50
Synthesis and biological activity of KCB-328 and its analogues: novel class III antiarrhythmic agents with little reverse frequency dependence.
D I Kim, H Y Kim, L S Kwon, S D Park, G H Jeon, K Y Jung, J K Min, W H Nam, K Lee, Y S Chung,[...]. Bioorg Med Chem Lett 1999
D I Kim, H Y Kim, L S Kwon, S D Park, G H Jeon, K Y Jung, J K Min, W H Nam, K Lee, Y S Chung,[...]. Bioorg Med Chem Lett 1999
50
Chronic haloperidol increases voltage-gated Na+ currents in mouse cortical neurons.
Weiqiang Chen, Fangfang Zhu, Jingfang Guo, Jiangtao Sheng, Wenli Li, Xiangfeng Zhao, Gefei Wang, Kangsheng Li. Biochem Biophys Res Commun 2014
Weiqiang Chen, Fangfang Zhu, Jingfang Guo, Jiangtao Sheng, Wenli Li, Xiangfeng Zhao, Gefei Wang, Kangsheng Li. Biochem Biophys Res Commun 2014
50
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.